NYSE:LCTX | EBITDA Margin | Lineage Cell Therapeutics, Inc.

Complete source-backed ebitda margin history.

Available history
2014-12-31 to 2023-03-31
Data captured

Historical EBITDA Margin

DateEBITDA Margin
2023-03-31-272.59%
2022-12-31-339.32%
2022-03-31-128.39%
2021-12-31-732.18%
2021-03-31-1758.57%
2020-12-31-1600.56%
2020-09-30-1142.73%
2020-06-30-1604.15%
2020-03-31-1405.84%
2019-12-31-534.73%
2019-09-30-1440.74%
2019-06-30-1357.77%
2019-03-31-1346.12%
2018-12-31-1312.40%
2018-09-30-1028.82%
2018-06-30-348.06%
2018-03-31-1698.43%
2017-12-31-929.53%
2017-09-30-548.82%
2017-06-30-2193.96%
2017-03-31-2832.31%
2016-12-31-1022.07%
2016-03-31-1125.37%

Annual EBITDA Margin

DateEBITDA Margin
2022-12-31-149.21%
2021-12-31-1118.36%
2020-12-31-1403.29%
2019-12-31-1077.50%
2018-12-31-816.24%
2017-12-31-1097.60%
2016-12-31-975.64%
2015-12-31-920.00%
2014-12-31-946.43%